CIR
AMGN icon

Clear Investment Research’s Amgen AMGN Stock Holding History

Clear Investment Research’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-21
Closed -$6.05K – 219
2023
Q4 		$6.05K Buy
+21
New +$5.72K 0.01% 200
2019
Q4 		– Sell
-7
Closed -$1K – 124
2019
Q3 		$1K Hold
7
– – ﹤0.01% 138
2019
Q2 		$1K Hold
7
– – ﹤0.01% 137
2019
Q1 		$1K Hold
7
– – ﹤0.01% 134
2018
Q4 		$1K Hold
7
– – ﹤0.01% 128
2018
Q3 		$1K Buy
+7
New +$1.38K ﹤0.01% 138

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Clear Investment Research's AMGN Position: Q1 2024 in Review

Clear Investment Research sold out of Amgen (AMGN) in Q1 2024, closing a stake of 21 shares — an estimated $6.05K sold.

Clear Investment Research first reported a position in AMGN in Q3 2018 and held it in 6 quarters. The position peaked at $6.05K in Q4 2023. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Clear Investment Research reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
  • Clear Investment Research sold 21 Amgen shares in Q1 2024, an estimated $6.05K.
  • Clear Investment Research first reported a position in Amgen in Q3 2018 and held it in 6 quarters.
  • Clear Investment Research's Amgen position peaked at $6.05K in Q4 2023.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Clear Investment Research's 13F filing for Q1 2024, filed 2 May 2024.